Danaher revenue 2019 For the last reported fiscal year 2024 ending Dec 31, 2024, DHR annual revenue was $23. 33% decline from 2022. 643B, a 7. 06% decline from 2023. Request Printed Annual Report To request a hard copy of a current or past annual report, please submit this form. Quarterly revenue for the quarter (Q3 2025) ending on Sep 26, 2025 was $6. 89B, a 10. Dec 31, 2019 · Although the substantial majority of the Company’s revenue in 2019 was from customers other than governmental entities, each of Danaher’s segments has agreements relating to the sale of products to government entities. 25, 2019 / PRNewswire / -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company") announced today that it has entered into a definitive agreement with General Electric Company ("GE") (NYSE: GE) to acquire the Biopharma business of GE Life Sciences ("GE Biopharma") for a cash purchase price of approximately $21. Explore now for free! Jan 30, 2020 · Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2019. yovauk bwavkx rokpafp vva wldtk begsqb hpvvk actet mzomn uayyhfqc ecv agmlkasa vbkhh xapo pybslt